Scott M. Coiante - SVP, Chief Financial Officer at Aprea Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP, Chief Financial Officer
Stock Symbol
APRE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Scott M. Coiante since 12/24/2023

Holdings reported by Scott M. Coiante for Aprea Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 145K $534K $3.68 Jul 28, 2022 Direct
Stock Option (right to Buy) 89.2K Jul 28, 2022 Direct Common Stock

Transactions reported by Scott M. Coiante for Aprea Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.